Glutamine supplementation in critically ill patients

Laura Pasin, Pasquale Nardelli, Desiderio Piras

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Glutamine supplementation in intensive care unit patients is supposed to improve outcome by modulating inflammatory response, preventing organ injury, modulating glucose metabolism and inducing cellular protection pathways. Trials showed conflicting results on mortality. Heyland et al showed a significant increase in mortality in critically ill patients who received glutamine supplementation. Their results were confirmed by a subsequent meta-analysis considering only high quality evidence. Therefore, glutamine supplementation should be avoided in this setting.

Original languageEnglish
Title of host publicationReducing Mortality in Critically Ill Patients
PublisherSpringer International Publishing
Pages117-122
Number of pages6
ISBN (Print)9783319175157, 9783319175140
DOIs
Publication statusPublished - Jan 1 2015

Keywords

  • Critically ill
  • Glutamine
  • Mortality

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Glutamine supplementation in critically ill patients'. Together they form a unique fingerprint.

  • Cite this

    Pasin, L., Nardelli, P., & Piras, D. (2015). Glutamine supplementation in critically ill patients. In Reducing Mortality in Critically Ill Patients (pp. 117-122). Springer International Publishing. https://doi.org/10.1007/978-3-319-17515-7_15